NuCana plc (ADR)
General ticker "NCNA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $90.5M (TTM average)
NuCana plc (ADR) does not follow the US Stock Market performance with the rate: -27.7%.
Estimated limits based on current volatility of 4.2%: low 2.08$, high 2.26$
Factors to consider:
- Total employees count: 20 as of 2017
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.86$, 7.33$]
- 2026-12-31 to 2027-12-31 estimated range: [1.52$, 5.65$]
Short-term NCNA quotes
Long-term NCNA plot with estimates
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | £0.00MM |
| Operating Expenses | £20.11MM |
| Operating Income | £-20.11MM |
| Non-Operating Income | £-10.41MM |
| R&D Expense | £12.74MM |
| Income(Loss) | £-30.52MM |
| Taxes | £-1.17MM |
| Net Income(Loss)* | £-28.71MM |
| Stockholders Equity | £24.33MM |
| Assets | £29.83MM |
| Operating Cash Flow | £-6.96MM |
| Investing Cash Flow | £-0.19MM |
| Financing Cash Flow | £24.46MM |
| Earnings Per Share** | £-7.77 |
| Ordinary share to ADR | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.